Ultrasonic Activation of Thermally Sensitive Liposomes
Cancerous cells are known to be more vulnerable to mild hyperthermia than healthy cells, which can survive temperatures above 43°C for brief periods of time. Currently in phase III clinical trials for liver cancer, ThermoDox® (Celsion Corporation) is a drug delivery system containing doxorubicin, a...
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2010
|